Skip to main content
FinSpry Logo
FinSpry
IOVA logo
IOVA
(NASDAQ)
Iovance Biotherapeutics, Inc.
$5.13-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Iovance Biotherapeutics (IOVA) Stock Price & Financial Analysis

Iovance Biotherapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$5.00 - $5.28
52-Week High$5.64
52-Week Low$1.76
Open$5.03
Volume9.73M
Average Volume (3M)15.66M
Market Cap2.15B
Shares Outstanding418.51M
Price to Sales (P/S)7.52
Price to Book (P/B)2.97
EV/EBITDA-6.22
Revenue (TTM)285.61M
Net Income (TTM)-353.86M
Free Cash Flow (TTM)-305.02M
EPS (TTM)$-0.93
Profit Margin-123.90%
Operating Margin-127.16%
Return on Equity (ROE)-49.03%
Debt to Equity0.07
50-Day MA$4.15
200-Day MA$3.22
52-Week Change29.22%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Iovance Biotherapeutics

What is the current stock price for IOVA?

As of the latest trading session, IOVA stock trades at $5.13. The 52-week range is $1.76–$5.64, with a day range of $5.00–$5.28.

What is the P/E ratio for IOVA?

The P/E ratio (Price-to-Earnings) for IOVA is shown in the Key Statistics section. This valuation metric helps compare Iovance Biotherapeutics, Inc. to industry peers.

Does IOVA pay dividends?

Iovance Biotherapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for IOVA?

Based on 6 analysts, the consensus for IOVA is Buy.

What is the market cap of IOVA?

Iovance Biotherapeutics's market capitalization is $2.15B, classifying it as a mid-cap company. Iovance Biotherapeutics operates in the Healthcare sector within the Biotechnology industry.